Mirian Stiebbe Salvadori

Prof. Dr. Mirian Stiebbe Salvadori

Psicologia, Federal University of Paraíba, João Pessoa, Paraíba, Brazil
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2013 in Neuroscience Journal
Verified
Journal Article
Open access
PDF file
CSCamila Carolina de Menezes Patrício Santos
Camila Carolina de Menezes Patrício Santos
Mirian Stiebbe SalvadoriMirian Stiebbe Salvadori
Mirian Stiebbe Salvadori
VMVanine Gomes Mota
Vanine Gomes Mota
LCLuciana Muratori Costa
Luciana Muratori Costa
AAAntonia Amanda Cardoso de Almeida
Antonia Amanda Cardoso de Almeida
RAReinaldo Nóbrega de Almeida
Reinaldo Nóbrega de Almeida
The objective of the present study was to evaluate the antinociceptive effects of phytol using chemical and thermal models of nociception in mice and to assess its antioxidant effectsin vitro. Phytol was administered intraperitoneally (i.p.) to mice at doses of 25, 50, 100, and 200 mg/kg. In the acetic acid-induced writhing test, phytol significantly reduced the number of contortions compared to the control group (P<0.001). In the formalin test, phytol reduced significantly the amount of time spent in paw licking in both phases (the neurogenic and inflammatory phases), this effect being more pronounced in the second phase (P<0.001). Phytol also provoked a significant increase in latency in the hot plate test. These antinociceptive effects did not impaire the motor performance, as shown in the rotarod test. Phytol demonstrated a strong antioxidant effectin vitroin its capacity to remove hydroxyl radicals and nitric oxide as well as to prevent the formation of thiobarbituric acid reactive substances (TBARS). Taken as a whole, these results show the pronounced antinociceptive effects of phytol in the nociception models used, both through its central and peripheral actions, but also its antioxidant properties demonstrated in thein vitromethods used.

22 November 2015 in Fundamental & Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
DFDiogo V. Fonsêca
Diogo V. Fonsêca
PSPaula R. R. Salgado
Paula R. R. Salgado
FCFabíola L. de Carvalho
Fabíola L. de Carvalho
Mirian Stiebbe SalvadoriMirian Stiebbe Salvadori
Mirian Stiebbe Salvadori
APAntônia Rosângela S. Penha
Antônia Rosângela S. Penha
RAReinaldo N. Almeida
Reinaldo N. Almeida

19 February 2014 in Flavour and Fragrance Journal
Verified
Journal Article
Closed access
PDF file
RSRenan O. Silva
Renan O. Silva
Mirian Stiebbe SalvadoriMirian Stiebbe Salvadori
Mirian Stiebbe Salvadori
FSFrancisca Beatriz M. Sousa
Francisca Beatriz M. Sousa
MSMaisa S. Santos
Maisa S. Santos
NCNathalia S. Carvalho
Nathalia S. Carvalho
JMJand Medeiros
Jand Medeiros

1 September 2014 in Neuroscience Letters
Verified
Journal Article
Closed access
MMMaria Rosilene Cândido Moreira
Maria Rosilene Cândido Moreira
Mirian Stiebbe SalvadoriMirian Stiebbe Salvadori
Mirian Stiebbe Salvadori
AAAntonia Amanda Cardoso de Almeida
Antonia Amanda Cardoso de Almeida
Damiao Pergentino de SousaDamiao Pergentino de Sousa
Damiao Pergentino de Sousa
Joaquin JordanJoaquin Jordan
Joaquin Jordan
RAReinaldo Nóbrega de Almeida
Reinaldo Nóbrega de Almeida

1 January 2014 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
FNFranklin F. F. Nóbrega
Franklin F. F. Nóbrega
Mirian Stiebbe SalvadoriMirian Stiebbe Salvadori
Mirian Stiebbe Salvadori
CMCintia J. Masson
Cintia J. Masson
CMCarlos F. Mello
Carlos F. Mello
TNTiago S. Nascimento
Tiago S. Nascimento
RAReinaldo N. Almeida
Reinaldo N. Almeida
Terpinen-4-ol (4TRP) is a monoterpenoid alcoholic component of essential oils obtained from several aromatic plants. We investigated the psychopharmacological and electrophysiological activities of 4TRP in male Swiss mice and Wistar rats. 4TRP was administered intraperitoneally (i.p.) at doses of 25 to 200 mg/kg and intracerebroventricularly (i.c.v.) at concentrations of 10, 20, and 40 ng/2 μL. For in vitro experiments, 4TRP concentrations were 0.1 mM and 1.0 mM. 4TRP (i.p.) inhibited pentylenetetrazol- (PTZ-) induced seizures, indicating anticonvulsant effects. Electroencephalographic recordings showed that 4TRP (i.c.v.) protected against PTZ-induced seizures, corroborating the behavioural results. To determine whether 4TRP exerts anticonvulsant effects via regulation of GABAergic neurotransmission, we measured convulsions induced by 3-mercapto-propionic acid (3-MP). The obtained results showed involvement of the GABAergic system in the anticonvulsant action exerted by 4TRP, but flumazenil, a selective antagonist of the benzodiazepine site of theGABAAreceptor, did not reverse the anticonvulsant effect, demonstrating that 4TRP does not bind to the benzodiazepine-binding site. Furthermore, 4TRP decreased the sodium current through voltage-dependent sodium channels, and thus its anticonvulsant effect may be related to changes in neuronal excitability because of modulation of these channels.

1 October 2021 in Journal of Affective Disorders
Verified
Journal Article
Closed access
NSNaís Lira Soares
Naís Lira Soares
VDVictor Augusto Mathias Dorand
Victor Augusto Mathias Dorand
HCHassler Clementino Cavalcante
Hassler Clementino Cavalcante
Kamila Sabino BatistaKamila Sabino Batista
Kamila Sabino Batista
DSDaniele Melo de Souza
Daniele Melo de Souza
JAJailane Aquino
Jailane Aquino